1 Artificial Intelligence (AI) Stock Down 53% to Buy on the Dip, According to Wall Street

Atlassian (TEAM) is integrating AI into its flagship products, Jira and Confluence, with its Rovo platform, aiming to boost long-term growth and customer spending; however, revenue growth has decelerated, with Q3 fiscal year 2025 revenue increasing 14% year-over-year to $1.35 billion, a slowdown from 30% in the prior year. Despite a net loss of $70.8 million in the recent quarter due to increased operating expenses, Wall Street analysts remain largely bullish, with an average price target suggesting a potential 37% upside, though bundled software sales could present a short-term headwind.

Analysis

Atlassian is strategically pivoting towards artificial intelligence by integrating its Rovo platform with core products like Jira and Confluence, aiming to drive long-term growth and enhance its ecosystem of over 300,000 enterprise customers. Despite the stock's nearly 24% rise over the past year, it remains 55% below its 2021 peak. In its fiscal 2025 third quarter, Atlassian reported record revenue of $1.35 billion, a 14% year-over-year increase; however, this represents a significant deceleration from the 30% growth in the prior-year quarter and 21% in the preceding quarter. Cloud revenue, constituting $880 million, grew 25%, while Data Center revenue increased 7% as the company transitions customers to its cloud offerings. Marketplace revenue saw a 5% decline. Positively, sales of Premium and Enterprise plans, which include Rovo, surged 40%, and 1.5 million individuals are now monthly active users of its AI products. This AI investment has driven operating expenses up by 20% to $1.15 billion, primarily due to a $109 million increase in R&D, resulting in a net loss of $70.8 million compared to a $12.7 million profit in the year-ago quarter. Wall Street analysts are predominantly bullish, with 19 of 33 tracked by The Wall Street Journal assigning a buy rating and an average price target suggesting 37% upside. The company's price-to-sales ratio has moderated to 11.1, below its three-year average of 13.6, indicating a potentially more attractive valuation. Management targets $10 billion in annual recurring revenue by around 2029, leveraging a $67 billion addressable market.

Key Decisions for Investors

• Investors should weigh Atlassian's significant AI-driven growth potential and strong analyst conviction against the current revenue growth deceleration and increased operating expenses impacting near-term profitability.
• Monitor the adoption rate of Rovo and the success of 'Collections' bundles, as these are key to future revenue acceleration and market share gains, though bundled pricing may create short-term revenue headwinds.
• Consider the current price-to-sales ratio of 11.1, which is below its historical average, as a potential entry point for long-term investors, acknowledging the path to $10 billion ARR by 2029 will likely involve further investment and potential volatility.